학술논문

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Document Type
Article
Source
Clinical & Applied Thrombosis/Hemostasis; Jan-Dec2023, Vol. 29, p1-10, 10p
Subject
RECOMBINANT erythropoietin
COVID-19
CRITICALLY ill
COHORT analysis
PROPENSITY score matching
Language
ISSN
10760296
Abstract
Copyright of Clinical & Applied Thrombosis/Hemostasis is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)